Mark Edinger

1.3k total citations
45 papers, 1.0k citations indexed

About

Mark Edinger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Edinger has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Mark Edinger's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Mark Edinger is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Mark Edinger collaborates with scholars based in United States, Australia and India. Mark Edinger's co-authors include Raymond R. Tubbs, Ronald M. Bukowski, Patricia Rayman, James H. Finke, Eric A. Klein, Jeannine Alexander, Barbara P. Barna, Sharad D. Deodhar, Jill Stanley and Raymond Tubbs and has published in prestigious journals such as The Journal of Immunology, Analytical Biochemistry and The Journal of Urology.

In The Last Decade

Mark Edinger

45 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Edinger United States 19 481 393 270 145 140 45 1.0k
Febe van Maldegem Netherlands 12 307 0.6× 235 0.6× 312 1.2× 114 0.8× 201 1.4× 20 858
E C Bradley United States 11 409 0.9× 423 1.1× 153 0.6× 56 0.4× 63 0.5× 17 878
M Giai Italy 18 165 0.3× 460 1.2× 474 1.8× 268 1.8× 106 0.8× 33 1.2k
W J Urba United States 18 510 1.1× 722 1.8× 252 0.9× 208 1.4× 202 1.4× 33 1.3k
Laith Dabbagh Canada 15 212 0.4× 546 1.4× 549 2.0× 160 1.1× 150 1.1× 23 1.3k
Laura V. Doyle United States 17 748 1.6× 393 1.0× 500 1.9× 272 1.9× 71 0.5× 27 1.5k
Roger Mouawad France 21 208 0.4× 308 0.8× 523 1.9× 177 1.2× 74 0.5× 57 968
NN Iscove Canada 16 491 1.0× 313 0.8× 444 1.6× 61 0.4× 76 0.5× 20 1.5k
Michiko Harao Japan 16 377 0.8× 329 0.8× 362 1.3× 132 0.9× 101 0.7× 36 915
SM Watt United Kingdom 13 369 0.8× 179 0.5× 394 1.5× 54 0.4× 89 0.6× 20 1.1k

Countries citing papers authored by Mark Edinger

Since Specialization
Citations

This map shows the geographic impact of Mark Edinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Edinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Edinger more than expected).

Fields of papers citing papers by Mark Edinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Edinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Edinger. The network helps show where Mark Edinger may publish in the future.

Co-authorship network of co-authors of Mark Edinger

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Edinger. A scholar is included among the top collaborators of Mark Edinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Edinger. Mark Edinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrews, Miles C., Roy E. Smith, Mark Edinger, et al.. (2023). Design, optimisation and standardisation of a high‐dimensional spectral flow cytometry workflow assessing T‐cell immunophenotype in patients with melanoma. Clinical & Translational Immunology. 12(9). e1466–e1466. 3 indexed citations
2.
Guryev, Oleg, et al.. (2012). Use of a new violet‐excitable AmCyan variant as a label in cell analysis. Cytometry Part A. 81A(7). 627–634. 4 indexed citations
3.
Sandhaus, Linda M., et al.. (1998). A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment.. PubMed. 26(1). 73–8. 10 indexed citations
4.
Rayman, Patricia, Mark Edinger, Raymond R. Tubbs, et al.. (1997). Defective Granzyme B Gene Expression and Lytic Response in T Lymphocytes Infiltrating Human Renal Cell Carcinoma. Journal of Immunotherapy. 20(6). 479–487. 23 indexed citations
5.
Kolenko, Vladimir, Qing Wang, John J. O’Shea, et al.. (1997). Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. The Journal of Immunology. 159(6). 3057–3067. 66 indexed citations
6.
Tanabe, Kazunari, Steven C. Campbell, Jeannine Alexander, et al.. (1997). Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma. Urological Research. 25(4). 231–238. 22 indexed citations
7.
Olencki, Thomas, James H. Finke, R Tubbs, et al.. (1996). Immunomodulatory Effects of Interleukin-2 and Interleukin-4 in Patients with Malignancy. Journal of Immunotherapy. 19(1). 69–80. 5 indexed citations
8.
Diaz, José I., et al.. (1996). Memory t cell subsets in b cell non-hodgkin's lymphomas. Leukemia & lymphoma. 20(3-4). 291–295. 2 indexed citations
9.
Steinbach, F., Jeannine Alexander, K. Tanabe, et al.. (1995). Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7. Urological Research. 23(3). 175–183. 5 indexed citations
10.
Wang, Qiu, O. Fernández Hidalgo, Pat Rayman, et al.. (1995). Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-hodgkin's lymphomas. Cancer Immunology Immunotherapy. 41(3). 175–184. 14 indexed citations
11.
Finke, James H., Patricia Rayman, Jeannine Alexander, et al.. (1994). Characterization of Tumor-Infiltrating Lymphocyte Subsets from Human Renal Cell Carcinoma: Specific Reactivity Defined by Cytotoxicity, Interferon-?? Secretion, and Proliferation. Journal of Immunotherapy. 15(2). 91–104. 48 indexed citations
12.
Bukowski, Ronald M., James H. Finke, Michael J. Caulfield, et al.. (1994). Phase I Trial of Cisplatin, WR-2721, and the Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma. Journal of Immunotherapy. 15(4). 273–282. 12 indexed citations
13.
Diaz, José I., Mark Edinger, Mark H. Stoler, & Raymond R. Tubbs. (1993). Host Tumor Infiltrating Lymphocytes in B Cell Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 9(1-2). 85–90. 9 indexed citations
14.
Lajoie, Ginette, I Zbieranowski, William A. Knape, et al.. (1993). A Comparative Study of DNA Quantitation in Breast Carcinoma With Image Cytometric Analysis andIn VitroFine-Needle Aspiration With Row Cytometric Analysis. American Journal of Clinical Pathology. 100(4). 456–462. 5 indexed citations
15.
Rayman, Patricia, Jill Stanley, James H. Finke, et al.. (1993). Interleukin 7 enhances the proliferation and effector function of tumor‐infiltrating lymphocytes from renal‐cell carcinoma. International Journal of Cancer. 53(6). 941–947. 18 indexed citations
16.
Finke, James H., Patricia Rayman, Mark Edinger, et al.. (1992). Characterization of a Human Renal Cell Carcinoma Specific Cytotoxic CD8+ T Cell Line. Journal of Immunotherapy. 11(1). 1–11. 76 indexed citations
17.
Gautam, Subhash C., James A. Matriano, Nathaniel F. Chikkala, Mark Edinger, & Raymond R. Tubbs. (1991). L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cellular Immunology. 135(1). 27–41. 40 indexed citations
18.
Segal, Glenn H., Mark Edinger, Michael D. Linden, et al.. (1991). Concomitant delineation of surface Ig, B‐cell differentiation antigens, and HLADR on lymphoid proliferations using three‐color immunocytometry. Cytometry. 12(4). 350–359. 23 indexed citations
19.
Majors, Anthony W., et al.. (1990). Phosphorus metabolites and the distribution of cell cycle phase of RIF‐1 tumors in response to 14 Gy irradiation. Magnetic Resonance in Medicine. 16(3). 425–430. 11 indexed citations
20.
Alexander, Jeannine, Patricia Rayman, Mark Edinger, et al.. (1990). Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity. International Journal of Cancer. 45(1). 119–124. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Febe van Maldegem Breakdown of academic impact, for papers by E C Bradley Breakdown of academic impact, for papers by M Giai Breakdown of academic impact, for papers by W J Urba Breakdown of academic impact, for papers by Laith Dabbagh Breakdown of academic impact, for papers by Laura V. Doyle Breakdown of academic impact, for papers by Roger Mouawad Breakdown of academic impact, for papers by NN Iscove Breakdown of academic impact, for papers by Michiko Harao Breakdown of academic impact, for papers by SM Watt
Rankless by CCL
2026